BCTXZ BriaCell Therapeutics Corp. War
$0.14▲ +26.40%
Unknown
Other
Volume 189.0K
Avg Volume (10D) –
Key Metrics & Fundamentals
Market Cap
–
P/E Ratio
–
Div Yield
–%
52W Range
0.10 - 0.15
% vs 50 MA
25.94%
% vs 200 MA
–%
RSI-14
52.1
MACD Histogram
+0.0000
Beta (1Y vs SPY)
-0.35
Free Cash Flow
-$7.15M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$7.43M
COGS
–
Operating Exp
$7.62M
Operating Income
-$7.62M
EBIT
-$7.62M
Pretax Income
-$7.24M
Net Income
-$7.16M
Price & Volume History
Loading chart…
Recent News
BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center
GlobeNewswire · Sep 8, 2026 11:30 AM
BriaCell Shares Turn Volatile After Melanoma Vaccine Development Milestone
InvestorsHub · Aug 24, 2026 12:47 PM
BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™
GlobeNewswire · Aug 24, 2026 11:30 AM
BriaCell Gets FDA Approval to Start Phase 1/2a of Prostate Cancer Immunotherapy Study
MT Newswires · Aug 5, 2026 7:03 PM
BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer
GlobeNewswire · Aug 5, 2026 11:30 AM
BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer
GlobeNewswire · Jul 16, 2026 11:30 AM
BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™
GlobeNewswire · Jul 15, 2026 11:30 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See BCTXZ's money flow as a full page
Social Sentiment
No Reddit posts found for BCTXZ.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.